Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Gabor Forgacs
AddedFeb 15, 2024
UpdatedMay 31, 2026
Gabor Forgacs

Gabor Forgacs

Founder, VivoSim Labs

CrunchbaseLinkedInThe Org

Gabor Forgacs's Career

VivoSim Labs
VivoSim Labs

San Diego, CA, US

Founder
Modern Meadow
Modern Meadow

Nutley, NJ, US

Co-Founder

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Gabor Forgacs's Career

VivoSim Labs
VivoSim Labs
Public$112.3M392011San Diego, CA, US
Founder

Leadership at VivoSim Labs

Douglas Jay CohenDouglas Jay CohenBoard Member
Adam K. SternAdam K. SternBoard Member
Taylor CrouchTaylor CrouchCEO
Keith MurphyKeith MurphyBoard Member
Eric DavidEric DavidBoard Member

Similar to VivoSim Labs

3DBio3DBioNew York City, NY, USLiving Tissuesest. 20143DBioNew York City, NY, US · est. 2014

3DBio Therapeutics: Precision bioprinting for regenerative medicine, creating custom living tissues.

Public · $500k39
HistogenHistogenSan Diego, CA, USMedical Technologiesest. 2007HistogenSan Diego, CA, US · est. 2007

San Diego-based Histogen Inc. innovates patented medical technologies for aesthetic and therapeutic tissue replacement.

Public · $87.5M7
3D Biotek3D BiotekNorth Brunswick, NJ, USBioprinting, Cell Cultureest. 20073D BiotekNorth Brunswick, NJ, US · est. 2007

3D Biotek LLC: A biotech firm specializing in manufacturing 3D cell culture devices since 2007.

Angel · $225k4
Precise BioPrecise BioWinston-Salem, NC, USBio-Fabricated Organsest. 2015Precise BioWinston-Salem, NC, US · est. 2015

Precise Bio: Innovating in regenerative medicine through 4D bio-fabrication of tissues and organs.

Series A · $27.5M33
Modern Meadow
Modern Meadow
Series C$183.6M1212011Nutley, NJ, US
Co-Founder

Leadership at Modern Meadow

Anna BakstAnna BakstBoard Member
Francois KressFrancois KressBoard Member
Doug MuzykaDoug MuzykaBoard Member
Bart SwansonBart SwansonBoard Member
Catherine Roggero-LovisiCatherine Roggero-LovisiCEO
Andras ForgacsAndras ForgacsCo-Founder

Similar to Modern Meadow

MycoWorksMycoWorksEmeryville, CA, USLeather Alternativesest. 2013MycoWorksEmeryville, CA, US · est. 2013

Emeryville-based MycoWorks, founded in 2013, innovatively produces leather-like products using mycelium biotechnology.

Series C · $187M160
Bolt Projects HoldingsBolt Projects HoldingsEmeryville, CA, USSustainable Materialsest. 2009Bolt Projects HoldingsEmeryville, CA, US · est. 2009

Bolt Threads: American manufacturer of sustainable materials for fashion and beauty industries.

Series E · $334.1M175
Uncaged InnovationsUncaged InnovationsWhite Plains, NY, USBiomaterials, Leather Alternativesest. 2020Uncaged InnovationsWhite Plains, NY, US · est. 2020

Uncaged Innovations: A biomaterials startup creating sustainable, ethical alternatives to animal leather.

Pre-Seed · $2.3M7
VitroLabsVitroLabsSan Jose, CA, USLeatherest. 2016VitroLabsSan Jose, CA, US · est. 2016

VitroLabs Inc: Innovating lab-grown leather through tissue engineering to combat climate change, cruelty-free.

Series A · $54.4M42

Gabor Forgacs's Similar Executives & Operators

Achmad ZakyAchmad ZakyCo-Founder · BukalapakNugroho HerucahyonoNugroho HerucahyonoCo-Founder · BukalapakBo ZhangBo ZhangCo-Founder · DiDiWILL WEI CHENGWILL WEI CHENGCo-Founder · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniFounder · Reliance RetailKim Beom-sooKim Beom-sooCo-Founder · KakaoBrian KimBrian KimCo-Founder · KakaoJB LEEJB LEECo-Founder · Kakao

People Similar to Gabor Forgacs

Alex ZehnbachtAlex ZehnbachtFounder · Mask.itRob MeadowsRob MeadowsFounder · OriginateMartin FernandezMartin FernandezCo-Founder · BTC TripVaibhav NivargiVaibhav NivargiCo-Founder · MoveworksIvan GurkinIvan GurkinCo-Founder · FooDoo